Hympavzi 150 mg solution for injection in pre-filled pen

Licence holder

Pfizer Europe MA EEIG (all products →)

Active substance

Marstacimab

Dosage form

Solution for injection in pre-filled pen

Route of administration

Subcutaneous use

ATC code

B02BX11

First authorised

18/11/2024

Prescription status

Product subject to prescription which may not be renewed (A)

Supply

Supply through pharmacies only

Legal basis

Full application (Article 8(3) of Directive No 2001/83/EC)

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.